This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Desire Collen: Innovator in Angiogenesis Research
Introduction
Desire Collen is a prominent inventor based in Belgium, known for his significant contributions to the field of angiogenesis research. His work primarily focuses on the development of therapeutic strategies targeting pathological angiogenesis, which is crucial in various diseases, including cancer and inflammatory disorders. Despite having no patents to his name, his research has led to groundbreaking inventions that hold promise for medical advancements.
Latest Patents
Desire Collen's latest patents include the "Use Of Inhibitors Of Placental Growth Factor For The Treatment Of Pathological Angiogenesis, Pathological Arteriogenesis, Inflammation, Tumour Formation And/or Vascular Leakage." This invention relates to the use of an angiogenesis inhibitor, specifically an antibody or a fragment that binds to placental growth factor (PlGF), for preparing a medicament aimed at treating conditions such as cancer, pulmonary hypertension, and inflammation. Another notable invention is the "Novel Anti-Plgf Antibody," which provides monoclonal antibodies directed to PlGF for the treatment and prevention of pathological angiogenesis.
Career Highlights
Desire Collen has worked with esteemed organizations, including the Flemish Interuniversity Institute for Biotechnology and the D. Collen Research Foundation. His career is marked by a commitment to advancing the understanding of angiogenesis and its implications in various diseases.
Collaborations
Throughout his career, Desire has collaborated with notable researchers such as Peter Carmeliet and Sandro De Falco. These collaborations have further enriched his research and contributed to the development of innovative therapeutic approaches.
Conclusion
Desire Collen's work in the field of angiogenesis research exemplifies the impact of innovative thinking in medicine. His contributions, particularly in developing therapies targeting placental growth factor, highlight the potential for advancements in treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile